The Kadence study is being conducted to evaluate the safety and efficacy of the study drug administered as a subcutaneous injection compared to an IV infusion in adults with uncontrolled gout. If approved, the subcutaneous administration of the study drug may offer a more convenient approach to managing uncontrolled gout.
This study is looking for about 270 adults who have been diagnosed with uncontrolled gout to participate.
What to Expect
• Regular visits and follow ups with a study team
• Study drug administration
• Safety monitoring
• Support from a study team
Why Consider Participating
• Every participant receives the study drug at no charge using one of two delivery methods
• Access to physicians with experience working with gout
• Reasonable reimbursements for travel-related expenses may be available
• Potentially help move research forward for other people with goutcipate.